ZA961000B - Use of HCP specific compounds to enhance erythropoiesis - Google Patents

Use of HCP specific compounds to enhance erythropoiesis

Info

Publication number
ZA961000B
ZA961000B ZA961000A ZA961000A ZA961000B ZA 961000 B ZA961000 B ZA 961000B ZA 961000 A ZA961000 A ZA 961000A ZA 961000 A ZA961000 A ZA 961000A ZA 961000 B ZA961000 B ZA 961000B
Authority
ZA
South Africa
Prior art keywords
specific compounds
hcp specific
enhance erythropoiesis
erythropoiesis
enhance
Prior art date
Application number
ZA961000A
Inventor
Damien John Dunnington
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA961000B publication Critical patent/ZA961000B/en

Links

ZA961000A 1995-02-10 1996-02-08 Use of HCP specific compounds to enhance erythropoiesis ZA961000B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38638195A 1995-02-10 1995-02-10

Publications (1)

Publication Number Publication Date
ZA961000B true ZA961000B (en) 1996-08-07

Family

ID=23525357

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA961001A ZA961001B (en) 1995-02-10 1996-02-08 Use of src SH2 specific compounds to treat a bone resorption disease
ZA961000A ZA961000B (en) 1995-02-10 1996-02-08 Use of HCP specific compounds to enhance erythropoiesis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA961001A ZA961001B (en) 1995-02-10 1996-02-08 Use of src SH2 specific compounds to treat a bone resorption disease

Country Status (2)

Country Link
TR (1) TR199700791T1 (en)
ZA (2) ZA961001B (en)

Also Published As

Publication number Publication date
ZA961001B (en) 1996-08-13
TR199700791T1 (en) 1998-03-21
MX9706130A (en) 1997-11-29

Similar Documents

Publication Publication Date Title
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL113248A0 (en) Use of alpha - 1c specific compounds
SG40869A1 (en) Use of pyrrole compounds as antifouling agents
IL116924A (en) Preparation of n-aryl - and n-hetarylhydroxylamines
GB9518215D0 (en) Improvements relating to telecines
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
ZA96725B (en) Use of phenyclyclohexylcarboxamides
PL327538A1 (en) Novel compounds of analgesic activity
GB9507297D0 (en) New composition of matter
AU4440596A (en) Use of hcp SH2 specific compounds to enhance erythropoiesis
PL311672A1 (en) Improvements related to block soap
EP0835104A4 (en) Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis
ZA932553B (en) New use of B-carbolines
GB9209925D0 (en) Improvements relating to chronographs
GB9200519D0 (en) Composition of matter
ZA961000B (en) Use of HCP specific compounds to enhance erythropoiesis
GB9525828D0 (en) Use of hetarylacetic acid derivatives
HUP9603028A3 (en) Use of aquous solution of l-triptophane-and/or l-threonine-salts
IL117786A (en) Preparation of alpha-bisoximes
ZA963825B (en) Composition of matter
GB9302184D0 (en) Improvements relating to the formation of cartosn
GR3035177T3 (en) Conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines
EP0845990A4 (en) New use of pregnane-diones as analgesic agents
IL117844A0 (en) Use of (s)-adenosyl-l-methionine
GB9523473D0 (en) Diagnosis of toxicoinfectious clostridiosis